Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Abstract

Cross-resistance to antitumor diarylsulfonylureas and collateral sensitivity to mitochondrial toxins in a human cell line selected for resistance to the antitumor agent N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)urea.

J Sosinski, J H Thakar, G S Germain, P Dias, F C Harwood, J F Kuttesch and P J Houghton
Molecular Pharmacology May 1994, 45 (5) 962-970;
J Sosinski
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J H Thakar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G S Germain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P Dias
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F C Harwood
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J F Kuttesch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P J Houghton
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 45 no. 5 962-970
PubMed 
7910660

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Published online May 1, 1994.


Author Information

  1. J Sosinski,
  2. J H Thakar,
  3. G S Germain,
  4. P Dias,
  5. F C Harwood,
  6. J F Kuttesch and
  7. P J Houghton
  1. Department of Molecular Pharmacology, St. Jude Children's Research Hospital, Memphis, Tennessee 38101.

    Statistics from Altmetric.com

    Article usage

    Article usage: January 1999 to May 2023

    AbstractFullPdf
    Jan 1999100
    Apr 2000100
    May 2000200
    Oct 2000100
    Jan 2001100
    Jul 2001100
    Aug 2001200
    Jan 2002200
    Apr 2002100
    May 2002200
    Jul 2003300
    Aug 2003400
    Sep 2003500
    Oct 2003600
    Nov 2003700
    Dec 2003600
    Jan 20041000
    Feb 2004400
    Mar 2004300
    Apr 2004300
    May 2004200
    Jun 2004500
    Jul 2004900
    Aug 2004500
    Sep 2004400
    Oct 2004600
    Nov 2004300
    Dec 2004200
    Jan 2005800
    Feb 2005500
    Mar 2005200
    Apr 2005100
    May 2005100
    Jun 2005200
    Jul 2005200
    Aug 2005100
    Oct 2005201
    Nov 2005101
    Dec 2005200
    Jan 2006100
    Feb 2006202
    Mar 2006401
    Apr 2006100
    May 2006105
    Jun 2006102
    Jul 2006100
    Aug 2006100
    Oct 2006202
    Nov 2006101
    Dec 2006300
    Jan 2007300
    Feb 2007100
    Mar 2007400
    Apr 2007001
    May 2007200
    Jun 2007101
    Jul 2007201
    Aug 2007102
    Sep 2007100
    Oct 2007101
    Nov 2007200
    Feb 2008300
    Mar 2008100
    Apr 2008300
    May 2008300
    Jun 2008300
    Jul 2008304
    Sep 2008102
    Oct 2008700
    Nov 2008503
    Dec 2008303
    Jan 2009200
    Feb 2009200
    Apr 2009201
    May 2009302
    Jul 2009101
    Aug 2009100
    Sep 2009400
    Oct 2009500
    Nov 2009200
    Dec 2009300
    Jan 2010203
    Feb 2010302
    Mar 2010300
    Apr 2010200
    May 2010200
    Jun 2010102
    Jul 2010900
    Aug 2010201
    Sep 2010805
    Oct 2010100
    Nov 2010100
    Dec 2010300
    Jan 2011300
    Feb 2011200
    Mar 2011300
    Apr 2011100
    May 2011303
    Jun 2011200
    Jul 2011300
    Sep 2011603
    Oct 2011300
    Nov 2011500
    Dec 2011201
    Jan 2012200
    Feb 2012102
    Mar 2012300
    Apr 2012100
    May 2012300
    Jun 2012300
    Aug 2012400
    Sep 2012200
    Nov 2012202
    Dec 2012001
    Jan 2013100
    Feb 2013201
    Apr 2013300
    May 2013500
    Jun 2013100
    Oct 2013502
    Nov 2013300
    Dec 2013001
    Jan 2014101
    Feb 2014101
    Mar 2014201
    May 20143701
    Sep 2014200
    Oct 2014600
    Nov 2014301
    Dec 2014200
    Jan 2015100
    Feb 2015404
    Mar 2015801
    Apr 2015200
    May 2015503
    Jun 2015301
    Jul 2015101
    Aug 2015300
    Sep 2015300
    Oct 2015101
    Nov 2015100
    Dec 2015301
    Jan 2016300
    Feb 2016600
    Mar 2016800
    Apr 2016201
    May 2016500
    Jun 2016100
    Aug 2016200
    Sep 2016300
    Oct 2016502
    Nov 2016100
    Dec 2016400
    Jan 2017502
    Feb 2017300
    Mar 2017200
    Jun 2017802
    Jul 2017600
    Aug 2017901
    Sep 2017300
    Oct 2017700
    Nov 2017600
    Dec 20171000
    Jan 20181800
    Feb 2018900
    Mar 2018800
    Apr 2018500
    May 2018600
    Jun 2018601
    Jul 2018601
    Aug 2018200
    Sep 2018101
    Oct 20181001
    Nov 2018100
    Dec 2018300
    Jan 2019300
    Feb 2019100
    Mar 2019701
    Apr 2019300
    May 2019300
    Jun 2019502
    Jul 2019100
    Aug 2019300
    Sep 2019600
    Oct 2019800
    Nov 2019900
    Dec 2019400
    Jan 2020100
    Feb 2020600
    Mar 2020300
    Apr 2020100
    May 20201000
    Jun 2020500
    Jul 2020100
    Aug 2020500
    Sep 20201200
    Oct 20201500
    Nov 2020400
    Dec 2020400
    Jan 2021600
    Feb 2021700
    Mar 2021600
    Apr 2021800
    May 20211400
    Jun 2021200
    Jul 2021600
    Aug 2021300
    Sep 2021400
    Oct 20211000
    Nov 20211300
    Dec 2021300
    Jan 20221400
    Feb 2022800
    Mar 2022501
    Apr 2022600
    May 2022300
    Jun 20221100
    Jul 20221300
    Aug 2022600
    Sep 2022400
    Oct 2022500
    Nov 2022600
    Dec 2022300
    Jan 2023300
    Feb 2023400
    Mar 2023400
    Apr 2023400
    May 2023501

    PreviousNext
    Back to top

    In this issue

    Molecular Pharmacology
    Vol. 45, Issue 5
    1 May 1994
    • Table of Contents
    • Table of Contents (PDF)
    • Index by author
    • Back Matter (PDF)
    • Editorial Board (PDF)
    • Front Matter (PDF)
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for sharing this Molecular Pharmacology article.

    NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

    Enter multiple addresses on separate lines or separate them with commas.
    Cross-resistance to antitumor diarylsulfonylureas and collateral sensitivity to mitochondrial toxins in a human cell line selected for resistance to the antitumor agent N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)urea.
    (Your Name) has forwarded a page to you from Molecular Pharmacology
    (Your Name) thought you would be interested in this article in Molecular Pharmacology.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Abstract

    Cross-resistance to antitumor diarylsulfonylureas and collateral sensitivity to mitochondrial toxins in a human cell line selected for resistance to the antitumor agent N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)urea.

    J Sosinski, J H Thakar, G S Germain, P Dias, F C Harwood, J F Kuttesch and P J Houghton
    Molecular Pharmacology May 1, 1994, 45 (5) 962-970;

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    Abstract

    Cross-resistance to antitumor diarylsulfonylureas and collateral sensitivity to mitochondrial toxins in a human cell line selected for resistance to the antitumor agent N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)urea.

    J Sosinski, J H Thakar, G S Germain, P Dias, F C Harwood, J F Kuttesch and P J Houghton
    Molecular Pharmacology May 1, 1994, 45 (5) 962-970;
    Reddit logo Twitter logo Facebook logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
    • Info & Metrics
    • eLetters
    • PDF

    Related Articles

    Cited By...

    Similar Articles

    Advertisement
    • Home
    • Alerts
    Facebook   Twitter   LinkedIn   RSS

    Navigate

    • Current Issue
    • Fast Forward by date
    • Fast Forward by section
    • Latest Articles
    • Archive
    • Search for Articles
    • Feedback
    • ASPET

    More Information

    • About Molecular Pharmacology
    • Editorial Board
    • Instructions to Authors
    • Submit a Manuscript
    • Customized Alerts
    • RSS Feeds
    • Subscriptions
    • Permissions
    • Terms & Conditions of Use

    ASPET's Other Journals

    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    ISSN 1521-0111 (Online)

    Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics